This compound is a small-molecule inhibitor targeting FMS-related receptor tyrosine kinase-3. It is under investigation for potential antineoplastic activity and is primarily used as a research compound in kinase studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Sitravatinib
pharmaceutical raw material
Liranaftate
pharmaceutical raw material
Fosinopril sodium
pharmaceutical raw material
Mesalazine
pharmaceutical raw material
Salicylhydroxamic acid
pharmaceutical raw material
5-cyano-N-[2-(cyclohexen-1-yl)-4-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]phenyl]-1H-imidazole-2-carboxamide
GUBJNPWVIUFSTR-UHFFFAOYSA-N
CN(C)CC(=O)N1CCC(CC1)C2=CC(=C(C=C2)NC(=O)C3=NC=C(N3)C#N)C4=CCCCC4
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.